Researchers at CHOP and University of Pennsylvania developed an online tool to refine results from RNA sequencing obtained from clinically accessible tissues.

Read about Dr. Peranteau’s journey to become a pediatric and fetal surgeon at CHOP, and his research studying the potential to fix defects in genes prenatally.

Joseph W. St. Geme, MD, Physician-in-Chief at Children’s Hospital of Philadelphia (CHOP), has been named the 2020 recipient of the Joseph W. St. Geme, Jr. Leadership Award.

Louis Bell, MD, Chief of the Division of General Pediatrics, shares the latest in medical thinking on an important topic: e-cigarettes.

New treatments put the brakes on an often-fatal degenerative muscle disease.

Laura Douglas, RN, BSN, is one of more than 300 PICU nurses who combine rigorous training with innate compassion to care for patients whose lives hang in the balance. This is a day in her life.

The incredible little girl who founded Alex’s Lemonade Stand was a patient at Children’s Hospital of Philadelphia (CHOP). Alex Scott was diagnosed with a rare cancer called neuroblastoma at CHOP just before she turned 1. CHOP doctors and nurses fought alongside Alex and her family as they went through the turmoil of pediatric cancer.

Congenital diaphragmatic hernia (CDH) is a complex and life-threatening birth defect usually discovered at an 18-week ultrasound visit. The CDH Program was recently designated as one of the hospital’s Frontier Programs, a trailblazing group of initiatives pioneering new advances in children’s health.

Palforzia TM is a new oral immunotherapy recently approved by the U.S. Food and Drug Administration to treat children with peanut allergies. The medication involves a daily controlled amount of peanut protein designed to desensitize children and reduce the severity of allergic reactions, some of which can be life-threatening.

Since 1986, the Auto Dealers Association of Greater Philadelphia (ADAGP) and its entities have donated $8.7 million to CHOP.